Global Medical Xynapse Overview

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 3

Global Medical Xynapse General Information

Description

Operator of a medical research company intended to focus on developing pharmaceutical products. The company's areas of expertise include researching and developing new drugs for various conditions, such as cancer, atopic dermatitis, and blood diseases, enabling the healthcare industry to keep patients healthy.

Contact Information

Website
gmex.co.kr
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Hanyang University FTC
  • 222 Wangsimni-ro, Seongdong-gu Fusion Tech Center Number 100-1202-7
  • Seoul
  • South Korea
+82
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • Hanyang University FTC
  • 222 Wangsimni-ro, Seongdong-gu Fusion Tech Center Number 100-1202-7
  • Seoul
  • South Korea
+82

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Global Medical Xynapse Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC Completed Clinical Trials - Phase 2
2. Seed Round 27-Jul-2021 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Global Medical Xynapse’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Global Medical Xynapse Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Global Medical Xynapse Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Seoul National University Technology Holdings Accelerator/Incubator Minority
BigBang Ventures Venture Capital Minority
Company X (Korea) Accelerator/Incubator Minority
To view Global Medical Xynapse’s complete investors history, request access »

Ready to get started?

Request a free trial

Global Medical Xynapse FAQs

  • Where is Global Medical Xynapse headquartered?

    Global Medical Xynapse is headquartered in Seoul, South Korea.

  • What is the size of Global Medical Xynapse?

    Global Medical Xynapse has 3 total employees.

  • What industry is Global Medical Xynapse in?

    Global Medical Xynapse’s primary industry is Drug Discovery.

  • Is Global Medical Xynapse a private or public company?

    Global Medical Xynapse is a Private company.

  • What is Global Medical Xynapse’s current revenue?

    The current revenue for Global Medical Xynapse is .

  • Who are Global Medical Xynapse’s investors?

    Seoul National University Technology Holdings, BigBang Ventures, and Company X (Korea) have invested in Global Medical Xynapse.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »